Expression of c-erbB-2 oncoprotein in human thyroid tumours

Histopathology

Volumn 34, Issue 1, 1999, Pages 60-65

  Utrilla, J C ^b   Martin Lacave I ^b   San Martin M V ^b   Fernandex Santos J M ^b   Galera Davidson, H ^a  

^a Facultad de Medicina   (Spain)

^b NONE

Author keywords

c erbB 2; Immunohistochemistry; Medullary thyroid carcinoma; Papillary thyroid carcinoma; Thyroid tumours

Indexed keywords

ONCOPROTEIN;

ANAPLASTIC CARCINOMA; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE C ERB; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

ADENOMA; CARCINOMA; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 0007935881     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1999.00563.x     Document Type: Article

References (25)

1. 1. Akiyama T, Sudo C, Ogawara H et al. The product of the human c-erbB-2: A 185-kilodalton glycoprotein with tyrosine kinase activity. Science 1986; 232; 1644-1646.
2. 2. Dougall WC, Qian X, Peterson NC et al. The neu-oncogene: signal transduction patways, transformation mechanisms and envolving therapies. Oncogene 1994; 9; 2109-2123.
3. 3. Yokota J, Yamamoto T, Toyoshima K et al. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet 1986; i; 765.
4. 4. Slamon DJ, Godolphin W, Jones LA et al. Studies of the c-erbB-2/ neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244; 707-712.
5. 5. D'Emilia J, Bulovas K, D'Ercole K et al. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon. Oncogene 1989; 4; 1233-1239.
6. 6. Hall PA, Hughes CM, Staddon SL et al. The c-erbB-2 proto-oncogene in pancreatic cancer. J. Pathol. 1990; 161; 195-200.
7. 7. Zoll B, Kynast B, Corell B et al. Alterations of the c-erbB-2 gene in human breast cancer. J. Cancer Res. Clin. Oncol. 1992; 118; 468-473.
8. 8. Sirvent JJ, Santafé M, Salvadó MT et al. Hormonal receptors, cell proliferation fraction (ki-67) and c-erbB-2 amplification in breast cancer. Relationship between differentiation degree and axillary lymph node metastasis. Histol. Histopathol. 1994; 9; 563-570.
9. 9. Aasland R, Lillehaug JR, Male R et al. Expression of oncogenes in thyroid tumours: Coexpression of c-erbB-2/neu and c-erbB. Br. J. Cancer 1988; 57; 358-363.
10. 10. Lemoine NK, Wyllie FS, Lillehaug JR et al. Absence of abnormalities of the c-erbB-1 and c-erbB-2 proto-oncogenes in human thyroid neoplasia. Eur. J. Cancer 1990; 26; 777-779.
11. 11. Soares P, Sambade C, Sobrinho-Simoes MA. Expression of c-erbB-2 in tumours and tumour-like lesions of the thyroid. Int. J. Cancer 1994; 56; 459-461.
12. 12. Haugen DRF, Akslen LA, Varhaug JE et al. Expression of c-erbB-2 protein in papillary thyroid carcinomas. Br. J. Cancer 1992; 65; 832-837.
13. 13. Roncalli M, Springall DR, Varndell IM et al. Oncoprotein immunoreactivity in human endocrine tumours. J. Pathol. 1991; 163; 117-127.
14. 14. Auguste LJ, Masood S, Westerband A et al. Oncoprotein expression in follicular neoplasms of the thyroid. Am. J. Surg. 1992; 164; 592-593.
15. 15. Shi SR, Key ME, Kalra KI. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: and enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem. 1991; 39; 741-748.
16. 16. Castilla-Guerra L, Moreno AM, Fernández-Moreno MC et al. Expression and prognostic value of c-erbB-2 oncogene product in human phaeochromocytomas. Histopathology 1997; 31; 144-149.
17. 17. De Potter CR, Van Daele S, Van de Vijver MJ et al. The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues. Histopathology 1989; 15; 351-362.
18. 18. Gusterson BA, Gullick WJ, Venter DJ et al. Immunohistochemical localization of c-erbB-2 in human breast carcinomas. Mol. Cell. 1988; 2; 383-391.
19. 19. Coombs LM, Pigott DA, Sweeney E et al. Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder. Br. J. Cancer 1991; 63; 601-608.
20. 20. Mori S, Akijama T, Morishita Y et al. Light and electron microscopical demonstration of c-erbB-2 gene product-like immunoreactivity in human malignant tumours. Virchows Arch. B 1987; 54; 8-15.
21. 21. Haugen DRF, Akslen LA, Varhaug JE et al. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas. Cancer Res. 1996; 56; 1184-1188.
22. 22. Fusco A, Grieco M, Santoro M et al. A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature 1987; 328; 170-172.
23. 23. Bongarzone I, Pierotti MA, Monzini N et al. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene 1989; 4; 1457-1462.
24. 24. Suarez HG, Du Villard JA, Caillou B et al. Detection of activated ras oncogenes in human thyroid carcinomas. Oncogene 1988; 2; 403-406.
25. 25. Basolo F, Pinchera A, Fugazzola L et al. Expression of p21 ras protein as a prognostic factor in papillary thyroid carcinomas. Eur. J. Cancer 1994; 30A; 171-174.